Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/8953
Title: Protective effect of bergapten in acetic acid-induced colitis in rats
Authors: Adakudugu, Emmanuel A.
Ameyaw, Elvis Ofori
Obese, Ernest
Biney, Robert Peter
Henneh, Isaac Tabiri
Aidoo, Douglas B.
Oge, Elizabeth N.
Attah, Isaac Y.
Obiri, David D.
Keywords: Pharmaceutical science
Immunology
Pathology
Physiology
Bergapten
Ulcerative colitis
Mast cells
immune modulators
Biological sciences
Health sciences
Gastrointestinal system
Pharmacology Evidence-based medicine
Issue Date: 2020
Publisher: Cell Press
Abstract: Bergapten (5-methoxysporalen) is a furanocoumarin extracted from several species of citrus and bergamot oil. Bergamot essential oil is used traditionally in the management of inflammatory conditions. Previous studies on bergapten have explored mainly its in vitro anti-inflammatory activities which include suppression of the expression and release of pro-inflammatory cytokines such as TNF-α and interleukins as well as prostaglandins. Bergapten enhances the clearance of neutrophils and macrophages from the site of inflammation and reduces oxidative stress by inhibition of reactive oxygen species (ROS). Bergapten was assessed for its anti-inflammatory properties in acetic acid-induced colitis. Animals were obtained and randomly placed in six (6) groups (n ¼ 5) after acclimatization. Colitis was induced by rectal administration using 4% v/v acetic acid in Sprague Dawley rats after pre-treatment for 5 days. Bergapten was administered at doses of 3, 10, and 30 mg kg 1 p.o. while the control group received saline 5 mL kg 1 p.o. and the standard drug employed was sulphasalazine at a dose of 500 mg kg 1. Assessments made for colon-weight-to-length ratio, colonic injury, and mucosal mast cell degranulation. There were reduced colon-weight-to-length ratios in animals treated with bergapten which was significant (p < 0.5) for doses 10 and 30 mg kg 1 compared to the disease control group Both macroscopic and microscopic damage were reduced as well, with a lesser percentage of degranulated mast cells. Macroscopic damage was reduced for bergapten at doses 10 and 30 mg kg 1 significantly at p < 0.5 and p < 0.001, respectively. Similarly, microscopic damage was reduced at p < 0.01 and p < 0.001 respectively for bergapten 10 and 30 mg kg 1. The reduction of degranulation by bergapten was significant at p < 0.001. There was generally reduced damage at inflammatory sites as well as decreased infiltration of inflammatory cells. Overall, bergapten reduces inflam- mation in acetic acid-induced colitis.
URI: http://hdl.handle.net/123456789/8953
Appears in Collections:School of Allied Health Sciences

Files in This Item:
File Description SizeFormat 
Protective effect of bergapten in acetic acid-induced colitis in rats.pdfMain article1.08 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.